Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

✍ Scribed by Martin E Gore; Clare L Griffin; Barry Hancock; Poulam M Patel; Lynda Pyle; Michael Aitchison; Nicholas James; Roderick TD Oliver; Jozef Mardiak; Tahera Hussain; Richard Sylvester; Mahesh KB Parmar; Patrick Royston; Peter FA Mulders

• Book ID: 117305789
• Publisher: The Lancet
• Year: 2010
• Tongue: English
• Weight: 226 KB
• Volume: 375
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(09)61921-8